Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Placebo Controlled Pilot Trial
Ontology highlight
ABSTRACT: Changes in gene expression were consistent with mechanism of action and show that clinical response to treatment with belimumab is associated with significant decrease in profibrotic genes and pathways. Additional study is needed to determine the role of belimumab in the treatment of dcSSc
ORGANISM(S): Homo sapiens
PROVIDER: GSE97248 | GEO | 2018/03/01
REPOSITORIES: GEO
ACCESS DATA